141 related articles for article (PubMed ID: 31233712)
1. LCN2-interacting proteins and their expression patterns in brain tumors.
Du Z; Wu B; Xia Q; Zhao Y; Lin L; Cai Z; Wang S; Li E; Xu L; Li Y; Xu H; Yin D
Brain Res; 2019 Oct; 1720():146304. PubMed ID: 31233712
[TBL] [Abstract][Full Text] [Related]
2. HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Koh SA; Lee KH
Oncol Rep; 2015 Oct; 34(4):2179-87. PubMed ID: 26259977
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
4. Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma.
Wu B; Li C; Du Z; Yao Q; Wu J; Feng L; Zhang P; Li S; Xu L; Li E
Sci Rep; 2014 Jun; 4():5403. PubMed ID: 24954627
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-2 elicited by advanced glycation end-products promotes the migration of vascular smooth muscle cells.
Chung TW; Choi HJ; Kim CH; Jeong HS; Ha KT
Biochim Biophys Acta; 2013 Dec; 1833(12):3386-3395. PubMed ID: 24149112
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
8. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.
Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820
[TBL] [Abstract][Full Text] [Related]
9. Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.
Rahimi S; Roushandeh AM; Ahmadzadeh E; Jahanian-Najafabadi A; Roudkenar MH
Mol Biol Rep; 2020 Mar; 47(3):2327-2346. PubMed ID: 31970626
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells.
Shiiba M; Saito K; Fushimi K; Ishigami T; Shinozuka K; Nakashima D; Kouzu Y; Koike H; Kasamatsu A; Sakamoto Y; Ogawara K; Uzawa K; Takiguchi Y; Tanzawa H
Int J Oncol; 2013 Apr; 42(4):1197-204. PubMed ID: 23403985
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix.
Wu CH; Ko JL; Chen SC; Lin YW; Han CP; Yang TY; Chien MH; Wang PH
Gynecol Oncol; 2014 Feb; 132(2):474-82. PubMed ID: 24316309
[TBL] [Abstract][Full Text] [Related]
12. Regulation by lipocalin-2 of neuronal cell death, migration, and morphology.
Lee S; Lee WH; Lee MS; Mori K; Suk K
J Neurosci Res; 2012 Mar; 90(3):540-50. PubMed ID: 22038922
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
Miyamoto T; Kashima H; Yamada Y; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
PLoS One; 2016; 11(5):e0155220. PubMed ID: 27168162
[TBL] [Abstract][Full Text] [Related]
16. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
Borkham-Kamphorst E; Drews F; Weiskirchen R
Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.
Kobara H; Miyamoto T; Suzuki A; Asaka R; Yamada Y; Ishikawa K; Kikuchi N; Ohira S; Shiozawa T
Placenta; 2013 Nov; 34(11):1036-43. PubMed ID: 23972287
[TBL] [Abstract][Full Text] [Related]
18. LCN2 Promoter Methylation Status as Novel Predictive Marker for Microvessel Density and Aggressive Tumor Phenotype in Breast Cancer Patients.
Meka Pb; Jarjapu S; Nanchari SR; Vishwakarma SK; Edathara PM; Gorre M; Cingeetham A; Vuree S; Annamaneni S; Dunna NR; Mukta S; B T; Satti V
Asian Pac J Cancer Prev; 2015; 16(12):4965-9. PubMed ID: 26163623
[TBL] [Abstract][Full Text] [Related]
19. A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
Xia Q; Du Z; Chen M; Zhou X; Bai W; Zheng X; Lin L; Zhao Y; Ding J; Wu Z; Zou H; Wang S; Xu L; Li E; Wu B
Mol Oncol; 2023 Nov; 17(11):2451-2471. PubMed ID: 37753805
[TBL] [Abstract][Full Text] [Related]
20. The role of lipocalin-2 in liver regeneration.
Kienzl-Wagner K; Moschen AR; Geiger S; Bichler A; Aigner F; Brandacher G; Pratschke J; Tilg H
Liver Int; 2015 Apr; 35(4):1195-202. PubMed ID: 25040147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]